NFX vs. PYC, EVG, OVB, APTA, FAB, OCTP, IXI, VAL, BSFA, and GENF
Should you be buying Nuformix stock or one of its competitors? The main competitors of Nuformix include Physiomics (PYC), Evgen Pharma (EVG), Ovoca Bio (OVB), Aptamer Group (APTA), Fusion Antibodies (FAB), Oxford Cannabinoid Technologies (OCTP), IXICO (IXI), ValiRx (VAL), BSF Enterprise (BSFA), and Genflow Biosciences (GENF). These companies are all part of the "biotechnology" industry.
Physiomics (LON:PYC) and Nuformix (LON:NFX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation.
Physiomics has higher revenue and earnings than Nuformix.
Nuformix has a net margin of 0.00% compared to Nuformix's net margin of -70.32%. Physiomics' return on equity of -27.25% beat Nuformix's return on equity.
Physiomics has a beta of 1.78, suggesting that its share price is 78% more volatile than the S&P 500. Comparatively, Nuformix has a beta of 0.29, suggesting that its share price is 71% less volatile than the S&P 500.
0.1% of Physiomics shares are owned by institutional investors. Comparatively, 0.2% of Nuformix shares are owned by institutional investors. 6.3% of Physiomics shares are owned by company insiders. Comparatively, 15.0% of Nuformix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Nuformix's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.
Physiomics received 12 more outperform votes than Nuformix when rated by MarketBeat users. However, 66.67% of users gave Nuformix an outperform vote while only 55.56% of users gave Physiomics an outperform vote.
Summary
Nuformix beats Physiomics on 8 of the 11 factors compared between the two stocks.
Get Nuformix News Delivered to You Automatically
Sign up to receive the latest news and ratings for NFX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nuformix Competitors List
Related Companies and Tools
